Industries > Pharma > Global Pre-Filled Syringes Market Forecast 2017-2027

Global Pre-Filled Syringes Market Forecast 2017-2027

Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors

PUBLISHED: 31 March 2017
PAGES: 211
PRODUCT CODE: PHA0180
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0180 Categories: , Tags: ,

The global pre-filled syringes market is expected to grow at a moderate growth rate over the forecast period. The global pre-filled syringes market was valued at $4,663m in 2016. Visiongain forecasts this market to increase to $7,629m in 2021. The market will then continue to increase to $12,764m in 2027, growing at a CAGR of 9.7% between 2016 and 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 211-page report you will receive 68 tables and 55 figures – all unavailable elsewhere.

The 211-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Pre-Filled Syringes Market Forecast 2017-2027

Report Scope
Global Pre-Filled Syringes market forecasts from 2017-2027

• Pre-Filled Syringes national market forecasts from 2017-2027, covering:
– United States
– Japan
– Germany
– France
– United Kingdom
– Italy
– Spain
– Brazil
– Russia
– India
– China

• Pre-Filled Syringes submarket forecasts from 2017-2027 covering:
Glass Pre-Filled Syringes
Pen Injectors and Autoinjectors
Plastic Pre-Filled Syringes

• Forecasts from 2017-2027 of the leading therapeutic sectors for the Pre-Filled Syringes market:
– Insulin Therapies
– Rheumatoid Arthritis (RA) Therapies
– Growth Hormones
– Vaccines
– PCSK9 Inhibitors

• Forecasts from 2017-2027 of the leading pre-filled devices:
– Lantus
– NovoRapid/Novolog
– Humalog
– Humira
– Enbrel
– Norditropin
– Genotropin
– Praluent
– Repatha

• Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers

SWOT and STEP analysis

Visiongain’s study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.

Buy our report today Global Pre-Filled Syringes Market Forecast 2017-2027: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category